NIH-funded research R01 grant

Understanding brain changes in a type of aphasia

Official title: Longitudinal multi-modality imaging in non-fluent/agrammatic primary progressive aphasia

Funded at Mayo Clinic Rochester · NIH-11137609 · Data updated 2026-11-12

This project looks at brain changes over time in people with a specific type of language disorder called non-fluent/agrammatic primary progressive aphasia.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startJuly 1, 2013
Project endJune 30, 2028
Funding year2025
Award (this year)$684,052
NIH project number5R01DC012519-13
Project IDNIH-11137609 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be individuals diagnosed with non-fluent/agrammatic primary progressive aphasia who are willing to participate in long-term imaging and blood sample collection.

Less likely to help

Patients without non-fluent/agrammatic primary progressive aphasia or those unable to undergo imaging or provide blood samples may not directly benefit from this specific research.

What this research studies

This project aims to understand how brain changes, like inflammation and protein buildup, contribute to a language disorder called non-fluent/agrammatic primary progressive aphasia (nfvPPA). Researchers are using advanced brain scans, called PET imaging, to see patterns of inflammation in the brain. They are also studying blood samples to find specific markers that might show what's happening in the brain. By following these changes over time, we hope to learn more about how nfvPPA progresses and affects language abilities.

Why it matters

Potential benefit: If successful, this work could lead to a better understanding of non-fluent/agrammatic primary progressive aphasia, potentially helping to identify new ways to diagnose or track the disease.

How similar studies have gone: Previous cycles of this grant have successfully characterized neurodegeneration and tau deposition in nfvPPA, indicating a foundation for this continued work.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Whitwell, Jennifer Louise — Mayo Clinic Rochester
  • Study coordinator: Whitwell, Jennifer Louise

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.